We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

178 hedge funds and large institutions have $661M invested in BioTelemetry, Inc. in 2017 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 60 increasing their positions, 55 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 20

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

29% more capital invested

Capital invested by funds: $512M → $661M (+$149M)

15% more call options, than puts

Call options by funds: $10.6M | Put options by funds: $9.19M

11% more funds holding

Funds holding: 160178 (+18)

9% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 55

Holders
178
Holders Change
+18
Holders Change %
+11.25%
% of All Funds
4.43%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
45
Increased
60
Reduced
55
Closed
20
Calls
$10.6M
Puts
$9.19M
Net Calls
+$1.37M
Net Calls Change
-$2.08M
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
51
JP Morgan Chase
New York
$2.53M -$1.33M -53,762 -38%
IA
52
Icon Advisers
Colorado
$2.5M -$1.48M -59,675 -41%
DIA
53
Dana Investment Advisors
Wisconsin
$2.48M +$2.12M +85,693 New
SI
54
Scout Investments
Missouri
$2.46M +$2.11M +85,075 New
Invesco
55
Invesco
Georgia
$2.38M +$51.5K +2,078 +3%
KBC Group
56
KBC Group
Belgium
$2.35M +$166K +6,688 +9%
FPC
57
Falcon Point Capital
California
$2.2M -$766K -30,930 -29%
Goldman Sachs
58
Goldman Sachs
New York
$2.2M -$683K -27,564 -27%
DCM
59
DAFNA Capital Management
California
$2.17M
CAM
60
ClariVest Asset Management
California
$2.03M +$9.91K +400 +0.6%
Two Sigma Investments
61
Two Sigma Investments
New York
$1.89M -$857K -34,600 -35%
FMBTD
62
First Midwest Bank Trust Division
Illinois
$1.85M +$35K +1,411 +2%
CCM
63
Cadence Capital Management
Massachusetts
$1.83M +$66.2K +2,673 +4%
VRS
64
Virginia Retirement Systems
Virginia
$1.81M +$1.55M +62,600 New
Barclays
65
Barclays
United Kingdom
$1.79M +$1.31M +52,842 +592%
CS
66
Credit Suisse
Switzerland
$1.68M +$528K +21,327 +58%
Citadel Advisors
67
Citadel Advisors
Florida
$1.61M +$1.11M +44,895 +418%
California State Teachers Retirement System (CalSTRS)
68
California State Teachers Retirement System (CalSTRS)
California
$1.54M -$61.9K -2,500 -4%
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
$1.53M +$396K +15,986 +43%
Prudential Financial
70
Prudential Financial
New Jersey
$1.41M -$300K -12,125 -20%
SAM
71
Sawgrass Asset Management
Florida
$1.38M +$232K +9,380 +25%
Legal & General Group
72
Legal & General Group
United Kingdom
$1.36M +$2.65K +107 +0.2%
TA
73
Teachers Advisors
New York
$1.35M +$81.7K +3,297 +8%
Swiss National Bank
74
Swiss National Bank
Switzerland
$1.27M
OAM
75
Oberweis Asset Management
Illinois
$1.25M -$166K -6,700 -13%

BEAT Hedge Fund Activity: Q1 2017 in Review

178 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q1 2017, worth a combined $661M — up 29% from $512M a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new BEAT positions and 20 closed out — a net gain of 25 holders — while 60 added to existing stakes and 55 trimmed.

The largest buyer was BlackRock, adding an estimated $86.8M. The largest seller was Acadian Asset Management, cutting an estimated $7.07M.

  • 178 institutional investors held BioTelemetry, Inc. (BEAT) as of Q1 2017, up from 160 in Q4 2016.
  • Funds reported $661M of BioTelemetry, Inc. stock for Q1 2017, up 29% quarter-over-quarter.
  • 45 funds opened new BioTelemetry, Inc. positions in Q1 2017 and 20 closed out, a net change of +25 holders.
  • The largest BioTelemetry, Inc. buyer in Q1 2017 was BlackRock, an estimated $86.8M added.
  • The largest BioTelemetry, Inc. seller in Q1 2017 was Acadian Asset Management, an estimated $7.07M sold.

Based on aggregated 13F filings for Q1 2017.